Approved lymphoma drug shows promise in early tests against bone cancer
Friday, November 6, 2009 - 06:35
in Health & Medicine
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice. While key experiments were in animals, the cancer studied closely resembled the human form and the drug has already been proven to be safe in human patients...
Read the whole article on Science Centric
More from Science Centric
Related
- Approved lymphoma drug shows promise in early tests against bone cancerThu, 5 Nov 2009, 11:53:38 EST
- Promising new drug blocks mutation in bone marrow cancersTue, 9 Dec 2008, 10:40:27 EST
- Anti-inflammatory drugs may defeat a treatment-resistant type of cancerWed, 24 Jun 2009, 16:39:03 EDT
- Drug shrinks lung cancer tumors in miceTue, 10 Nov 2009, 13:39:02 EST
- Study identifies causes of bone loss in breast cancer survivorsWed, 19 Nov 2008, 17:43:39 EST